Low-dose CDK4/6 inhibitors induce presentation of pathway specific MHC ligands as potential targets for cancer immunotherapy

por Charles, Angel, Bourne, Christopher M., Korontsvit, Tanya, Aretz, Zita E. H., Mun, Sung Soo, Dao, Tao, Klatt, Martin G., Scheinberg, David A.
Publicado 2021

Solving an MHC allele–specific bias in the reported immunopeptidome

por Klatt, Martin G., Mack, Kyeara N., Bai, Yang, Aretz, Zita E. H., Nathan, Levy I., Mun, Sung Soo, Dao, Tao, Scheinberg, David A.
Publicado 2020

Dual targeting ovarian cancer by Muc16 CAR-T cells secreting a bispecific T cell engager antibody for an intracellular tumor antigen WT1

por Mun, Sung Soo, Peraro, Leila, Meyerberg, Jeremy, Korontsvit, Tatyana, Malviya, Manish, Gardner, Thomas, Kyi, Chrisann, O’Cearbhaill, Roisin E., Liu, Cheng, Dao, Tao, Scheinberg, David A.
Publicado 2023

Unmasking the suppressed immunopeptidome of EZH2-mutated diffuse large B-cell lymphomas through combination drug treatment

por Bourne, Christopher M., Mun, Sung Soo, Dao, Tao, Aretz, Zita E. H., Molvi, Zaki, Gejman, Ron S., Daman, Andrew, Takata, Katsuyoshi, Steidl, Christian, Klatt, Martin G., Scheinberg, David A.
Publicado 2022

Depleting T regulatory cells by targeting intracellular Foxp3 with a TCR mimic antibody

por Dao, Tao, Mun, Sung Soo, Scott, Andrew C., Jarvis, Casey A., Korontsvit, Tatyana, Yang, Zhiyuan, Liu, Lianxing, Klatt, Martin G., Guerreiro, Manuel, Selvakumar, Annamalai, Brea, Elliott J., Oh, Claire, Liu, Cheng, Scheinberg, David A.
Publicado 2019

2-O, 3-O desulfated heparin (ODSH) increases bacterial clearance and attenuates lung injury in cystic fibrosis by restoring HMGB1-compromised macrophage function

por Wang, Mao, Gauthier, Alex G., Kennedy, Thomas P., Wang, Haichao, Velagapudi, Uday Kiran, Talele, Tanaji T., Lin, Mosi, Wu, Jiaqi, Daley, LeeAnne, Yang, Xiaojing, Patel, Vivek, Mun, Sung Soo, Ashby, Charles R., Mantell, Lin L.
Publicado 2021

Correction to: 2‑O, 3‑O desulfated heparin (ODSH) increases bacterial clearance and attenuates lung injury in cystic fibrosis by restoring HMGB1‑compromised macrophage function...

por Wang, Mao, Gauthier, Alex G., Kennedy, Thomas P., Wang, Haichao, Velagapudi, Uday Kiran, Talele, Tanaji T., Lin, Mosi, Wu, Jiaqi, Daley, LeeAnne, Yang, Xiaojing, Patel, Vivek, Mun, Sung Soo, Ashby, Charles R., Mantell, Lin L.
Publicado 2021

A TCR mimic monoclonal antibody reactive with the “public” phospho-neoantigen pIRS2/HLA-A*02:01 complex

por Dao, Tao, Mun, Sung Soo, Molvi, Zaki, Korontsvit, Tatyana, Klatt, Martin G., Khan, Abdul G., Nyakatura, Elisabeth K., Pohl, Mary Ann, White, Thomas E., Balderes, Paul J., Lorenz, Ivo C., O’Reilly, Richard J., Scheinberg, David A.
Publicado 2022

Tumor-associated antigen PRAME exhibits dualistic functions that are targetable in diffuse large B cell lymphoma

por Takata, Katsuyoshi, Chong, Lauren C., Ennishi, Daisuke, Aoki, Tomohiro, Li, Michael Yu, Thakur, Avinash, Healy, Shannon, Viganò, Elena, Dao, Tao, Kwon, Daniel, Duns, Gerben, Nielsen, Julie S., Ben-Neriah, Susana, Tse, Ethan, Hung, Stacy S., Boyle, Merrill, Mun, Sung Soo, Bourne, Christopher M., Woolcock, Bruce, Telenius, Adèle, Kishida, Makoto, Rai, Shinya, Zhang, Allen W., Bashashati, Ali, Saberi, Saeed, D’Antonio, Gianluca, Nelson, Brad H., Shah, Sohrab P., Hoodless, Pamela A., Melnick, Ari M., Gascoyne, Randy D., Connors, Joseph M., Scheinberg, David A., Béguelin, Wendy, Scott, David W., Steidl, Christian
Publicado 2022